Drug comparisons
Insulin Degludec vs Troglitazone
Insulin Degludec vs Troglitazone comparison for diabetes. Degludec is long-acting insulin; Troglitazone withdrawn for liver toxicity in 2000.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when reviewing historical versus current diabetes treatments or inquiring about withdrawn TZDs like Troglitazone.
Bottom line
Insulin Degludec is the appropriate current option since Troglitazone is discontinued due to hepatotoxicity risks.
All medication comparisons